Patents by Inventor Jonghwa JIN

Jonghwa JIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220334124
    Abstract: The present invention relates to a composition for screening various signal peptides to select specific ones that allow efficient secretion of a target protein to out of host cells. The present invention also relates to a method for selecting specific signal peptides that express a target protein in host cells and efficiently secrete the target protein to out of the host cells. The use of the composition and/or method according to the present invention enables ultrafast selection of optimal signal peptides for a target protein through barcoding sequences corresponding to the signal peptides, leading to the maximization of the production yield of the recombinant protein.
    Type: Application
    Filed: September 3, 2020
    Publication date: October 20, 2022
    Applicants: OSONG MEDICAL INNOVATION FOUNDATION
    Inventors: Sung Sub KIM, So Young CHOI, Ji Hoon PARK, Jonghwa JIN, Myung-Hee JANG
  • Patent number: 9945874
    Abstract: The present invention relates to a marker which can be used to diagnose a diabetic retinopathy patient and determine the progression of diabetic retinopathy, a composition for diagnosing diabetic retinopathy, which comprises an agent for measuring the level of a gene or protein associated with the marker, and the use thereof.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: April 17, 2018
    Assignees: LG ELECTRONICS INC., SNU R&DB FOUNDATION
    Inventors: Yunhee Ku, Yongju Yang, Youngsoo Kim, Jonghwa Jin, Kyunggon Kim, Moosub Kim, Seungyeon Song
  • Patent number: 9938561
    Abstract: Provided is a method for diagnosing cancer through a difference with a control group in view of the ratio of a deglycosylated peptide fragment and a non-glycosylated peptide fragment in a protein including an N-linked glycosylation motif. Further provided is a method for diagnosing cancer through the detection of the glycosylation ratio in the protein according to the subject matter enables the diagnosis of cancer with high specificity and sensitivity using at least one existing marker, and can be useful in discovering new markers for diagnosing cancer.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: April 10, 2018
    Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Youngsoo Kim, Jung-Hwan Yoon, Hyunsoo Kim, Kyunggon Kim, Jonghwa Jin
  • Publication number: 20160168618
    Abstract: Provided is a method for diagnosing cancer through a difference with a control group in view of the ratio of a deglycosylated peptide fragment and a non-glycosylated peptide fragment in a protein including an N-linked glycosylation motif. Further provided is a method for diagnosing cancer through the detection of the glycosylation ratio in the protein according to the subject matter enables the diagnosis of cancer with high specificity and sensitivity using at least one existing marker, and can be useful in discovering new markers for diagnosing cancer.
    Type: Application
    Filed: July 17, 2014
    Publication date: June 16, 2016
    Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Youngsoo KIM, Jung-Hwan YOON, Hyunsoo KIM, Kyunggon KIM, Jonghwa JIN
  • Publication number: 20160018415
    Abstract: The present invention relates to a marker which can be used to diagnose a diabetic retinopathy patient and determine the progression of diabetic retinopathy, a composition for diagnosing diabetic retinopathy, which comprises an agent for measuring the level of a gene or protein associated with the marker, and the use thereof.
    Type: Application
    Filed: September 29, 2015
    Publication date: January 21, 2016
    Applicants: SNU R&DB FOUNDATION, LG Electronics Inc.
    Inventors: Yunhee KU, Yongju YANG, Youngsoo KIM, Jonghwa Jin, Kyunggon Kim, Moosub KIM, Seungyeon SONG
  • Publication number: 20140087965
    Abstract: The present invention relates to a marker which can be used to diagnose a diabetic retinopathy patient and determine the progression of diabetic retinopathy, a composition for diagnosing diabetic retinopathy, which comprises an agent for measuring the level of a gene or protein associated with the marker, and the use thereof.
    Type: Application
    Filed: September 25, 2013
    Publication date: March 27, 2014
    Applicants: SNU R&DB FOUNDATION, LG ELECTRONICS INC.
    Inventors: Yunhee KU, Youngsoo KIM, Seungyeon SONG, Jonghwa JIN, Moosub KIM, Yongju YANG
  • Publication number: 20140004524
    Abstract: The present invention relates to a marker which can be used to diagnose a diabetic retinopathy patient and determine the progression of diabetic retinopathy, a composition for diagnosing diabetic retinopathy, which comprises an agent for measuring the level of a gene or protein associated with the marker, and the use thereof.
    Type: Application
    Filed: June 18, 2013
    Publication date: January 2, 2014
    Inventors: Yunhee KU, Yongju YANG, Youngsoo KIM, Jonghwa JIN, Kyunggon KIM, Moosub KIM, Seungyeon SONG